These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30518548)

  • 1. CAP2 mutation leads to impaired actin dynamics and associates with supraventricular tachycardia and dilated cardiomyopathy.
    Aspit L; Levitas A; Etzion S; Krymko H; Slanovic L; Zarivach R; Etzion Y; Parvari R
    J Med Genet; 2019 Apr; 56(4):228-235. PubMed ID: 30518548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A homozygous CAP2 pathogenic variant in a neonate presenting with rapidly progressive cardiomyopathy and nemaline rods.
    Gurunathan S; Sebastian J; Baker J; Abdel-Hamid HZ; West SC; Feingold B; Peche V; Reyes-Múgica M; Madan-Khetarpal S; Field J
    Am J Med Genet A; 2022 Mar; 188(3):970-977. PubMed ID: 34862840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole exome sequencing identified 1 base pair novel deletion in BCL2-associated athanogene 3 (BAG3) gene associated with severe dilated cardiomyopathy (DCM) requiring heart transplant in multiple family members.
    Rafiq MA; Chaudhry A; Care M; Spears DA; Morel CF; Hamilton RM
    Am J Med Genet A; 2017 Mar; 173(3):699-705. PubMed ID: 28211974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel alpha-tropomyosin mutation associates with dilated and non-compaction cardiomyopathy and diminishes actin binding.
    van de Meerakker JB; Christiaans I; Barnett P; Lekanne Deprez RH; Ilgun A; Mook OR; Mannens MM; Lam J; Wilde AA; Moorman AF; Postma AV
    Biochim Biophys Acta; 2013 Apr; 1833(4):833-9. PubMed ID: 23147248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Missense Variation in
    Majdalani P; Levitas A; Krymko H; Slanovic L; Braiman A; Hadad U; Dabsan S; Horev A; Zarivach R; Parvari R
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D117N in Cypher/ZASP may not be a causative mutation for dilated cardiomyopathy and ventricular arrhythmias.
    Levitas A; Konstantino Y; Muhammad E; Afawi Z; Marc Weinstein J; Amit G; Etzion Y; Parvari R
    Eur J Hum Genet; 2016 May; 24(5):666-71. PubMed ID: 26419279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ablation of cyclase-associated protein 2 (CAP2) leads to cardiomyopathy.
    Peche VS; Holak TA; Burgute BD; Kosmas K; Kale SP; Wunderlich FT; Elhamine F; Stehle R; Pfitzer G; Nohroudi K; Addicks K; Stöckigt F; Schrickel JW; Gallinger J; Schleicher M; Noegel AA
    Cell Mol Life Sci; 2013 Feb; 70(3):527-43. PubMed ID: 22945801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supraventricular tachycardias, conduction disease, and cardiomyopathy in 3 families with the same rare variant in TNNI3K (p.Glu768Lys).
    Podliesna S; Delanne J; Miller L; Tester DJ; Uzunyan M; Yano S; Klerk M; Cannon BC; Khongphatthanayothin A; Laurent G; Bertaux G; Falcon-Eicher S; Wu S; Yen HY; Gao H; Wilde AAM; Faivre L; Ackerman MJ; Lodder EM; Bezzina CR
    Heart Rhythm; 2019 Jan; 16(1):98-105. PubMed ID: 30010057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A substitution mutation in cardiac ubiquitin ligase, FBXO32, is associated with an autosomal recessive form of dilated cardiomyopathy.
    Al-Hassnan ZN; Shinwari ZM; Wakil SM; Tulbah S; Mohammed S; Rahbeeni Z; Alghamdi M; Rababh M; Colak D; Kaya N; Al-Fayyadh M; Alburaiki J
    BMC Med Genet; 2016 Jan; 17():3. PubMed ID: 26768247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNNI3K mutation in familial syndrome of conduction system disease, atrial tachyarrhythmia and dilated cardiomyopathy.
    Theis JL; Zimmermann MT; Larsen BT; Rybakova IN; Long PA; Evans JM; Middha S; de Andrade M; Moss RL; Wieben ED; Michels VV; Olson TM
    Hum Mol Genet; 2014 Nov; 23(21):5793-804. PubMed ID: 24925317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting MRTF/SRF in CAP2-dependent dilated cardiomyopathy delays disease onset.
    Xiong Y; Bedi K; Berritt S; Attipoe BK; Brooks TG; Wang K; Margulies KB; Field J
    JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30762586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic mutation of familial dilated cardiomyopathy based on next‑generation semiconductor sequencing.
    Lin XF; Luo JW; Liu G; Zhu YB; Jin Z; Lin X
    Mol Med Rep; 2018 Nov; 18(5):4271-4280. PubMed ID: 30221713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GATA5 loss-of-function mutation in familial dilated cardiomyopathy.
    Zhang XL; Dai N; Tang K; Chen YQ; Chen W; Wang J; Zhao CM; Yuan F; Qiu XB; Qu XK; Yang YQ; Xu YW
    Int J Mol Med; 2015 Mar; 35(3):763-70. PubMed ID: 25543888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CAP2 in cardiac conduction, sudden cardiac death and eye development.
    Field J; Ye DZ; Shinde M; Liu F; Schillinger KJ; Lu M; Wang T; Skettini M; Xiong Y; Brice AK; Chung DC; Patel VV
    Sci Rep; 2015 Nov; 5():17256. PubMed ID: 26616005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exome Sequencing Identifies a Novel LMNA Splice-Site Mutation and Multigenic Heterozygosity of Potential Modifiers in a Family with Sick Sinus Syndrome, Dilated Cardiomyopathy, and Sudden Cardiac Death.
    Zaragoza MV; Fung L; Jensen E; Oh F; Cung K; McCarthy LA; Tran CK; Hoang V; Hakim SA; Grosberg A
    PLoS One; 2016; 11(5):e0155421. PubMed ID: 27182706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mutation in the glutamate-rich region of RNA-binding motif protein 20 causes dilated cardiomyopathy through missplicing of titin and impaired Frank-Starling mechanism.
    Beqqali A; Bollen IA; Rasmussen TB; van den Hoogenhof MM; van Deutekom HW; Schafer S; Haas J; Meder B; Sørensen KE; van Oort RJ; Mogensen J; Hubner N; Creemers EE; van der Velden J; Pinto YM
    Cardiovasc Res; 2016 Oct; 112(1):452-63. PubMed ID: 27496873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy.
    Norton N; Li D; Rieder MJ; Siegfried JD; Rampersaud E; Züchner S; Mangos S; Gonzalez-Quintana J; Wang L; McGee S; Reiser J; Martin E; Nickerson DA; Hershberger RE
    Am J Hum Genet; 2011 Mar; 88(3):273-82. PubMed ID: 21353195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low mutation rate in the TTN gene in paediatric patients with dilated cardiomyopathy - a pilot study.
    Zaklyazminskaya E; Mikhailov V; Bukaeva A; Kotlukova N; Povolotskaya I; Kaimonov V; Dombrovskaya A; Dzemeshkevich S
    Sci Rep; 2019 Nov; 9(1):16409. PubMed ID: 31712709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in PDLIM5 are rare in dilated cardiomyopathy but are emerging as potential disease modifiers.
    Verdonschot JAJ; Robinson EL; James KN; Mohamed MW; Claes GRF; Casas K; Vanhoutte EK; Hazebroek MR; Kringlen G; Pasierb MM; van den Wijngaard A; Glatz JFC; Heymans SRB; Krapels IPC; Nahas S; Brunner HG; Szklarczyk R
    Mol Genet Genomic Med; 2020 Feb; 8(2):e1049. PubMed ID: 31880413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metavinculin mutations alter actin interaction in dilated cardiomyopathy.
    Olson TM; Illenberger S; Kishimoto NY; Huttelmaier S; Keating MT; Jockusch BM
    Circulation; 2002 Jan; 105(4):431-7. PubMed ID: 11815424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.